Pro12Ala PPAR γ2 gene polymorphism in PCOS women: The role of compounds regulating satiety

Gynecological Endocrinology

Volumn 28, Issue 3, 2012, Pages 195-198

  Bidzińska Speichert, Bozena ^a   Lenarcik, Agnieszka ^a   Tworowska Bardzińska, Urszula ^a   Ślȩzak, Ryszard ^a   Bednarek Tupikowska, Grazyna ^a   Milewicz, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

CCK; Galanin; Leptin; NPY; PCOS; Pro12Ala PPAR 2 polymorphism

Indexed keywords

ALANINE; CHOLECYSTOKININ; GALANIN; LEPTIN; NEUROPEPTIDE Y; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE;

ADULT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SATIETY;

ADULT; BODY MASS INDEX; CHOLECYSTOKININ; FEMALE; GALANIN; GENOTYPE; HUMANS; HYPERANDROGENISM; INSULIN RESISTANCE; LEPTIN; NEUROPEPTIDE Y; OBESITY; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; PPAR GAMMA; SATIATION;

EID: 84856907990     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.593670     Document Type: Article

References (32)

1. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-2438. (Pubitemid 32269197)
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil and Steril 2004;81:19-25.
3. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey W T. The metabolic signifcance of leptin in humans: Gender-based diferences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997;82:1293-1300. (Pubitemid 27166679)
4. Sepilian VP, Crochet JR, Nagamani M. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: Relationship to insulin resistance and androgens. Fertil Steril 2006;85: 1441-1447.
5. Bray GA, Atkinson RL. New weight guidelines for Americans. Am J Clin Nutr 1992;55:481-483.
6. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410. (Pubitemid 32269192)
7. Ahrén B, Holst JJ, Efendic S. Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes. J Clin Endocrinol Metab 2000;85:1043-1048. (Pubitemid 32269347)
8. Schwartz M W, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, et al. Specifcity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996;45:531-535. (Pubitemid 26111317)
9. Milewicz A, Bidzinska B, Mikulski E, Demissie M, Tworowska U. Infuence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels. Gynecol Endocrinol 2000;13:1-8.
10. Baranowska B, Chmielowska M, Radzikowska M, Borowiec M, Roguski K, Wasilewska-Dziubinska E. Efects of neuropeptide Y (NPY), galanin and vasoactive intestinal peptide (VIP) on pituitary hormone release and on ovarian steroidogenesis. Neuro Endocrinol Lett 1999;20:385-389. (Pubitemid 30025838)
11. Brzechfa PR, Jakimiuk AJ, Agarwal SK, Weitsman SR, Buyalos RP, Magofn DA. Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:4166-4169. (Pubitemid 26380435)
12. Zukauskaite S, Seibokaite A, Lasas L, Lasiene D, Urbonaite B, Kiesylyte J. Serum hormone levels and anthropometric characteristics in girls with hyperandrogenism. Medicina (Kaunas) 2005;41:305-312.
13. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Kaplinski A, Roguski K, Plonowski A. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Gynecol Endocrinol 1999;13:344-351. (Pubitemid 29511942)
14. Mantzoros CS, Dunaif A, Flier JS. Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:1687-1691. (Pubitemid 127495169)
15. Rouru J, Anttila L, Koskinen P, Penttilä TA, Irjala K, Huupponen R, Koulu M. Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:1697-1700. (Pubitemid 127495171)
16. Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM, Lombardi G, Lobo RA. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005;152:389-394. (Pubitemid 40439491)
17. Bray GA. Food intake, sympathetic activity, and adrenal steroids. Brain Res Bull 1993;32:537-541. (Pubitemid 23251961)
18. Kalra S P, Kalra PS. Neuropeptide Y: A physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 2003;22:49-56.
19. Leibowitz SF, Akabayashi A, Alexander JT, Wang J. Gonadal steroids and hypothalamic galanin and neuropeptide Y: Role in eating behavior and body weight control in female rats. Endocrinology 1998;139:1771-1780. (Pubitemid 28513836)
20. Egido EM, Hernández R, Leprince J, Chartrel N, Vaudry H, Marco J, Silvestre RA. 26RFa, a novel orexigenic neuropeptide, inhibits insulin secretion in the rat pancreas. Peptides 2007;28:725-730. (Pubitemid 46349320)
21. Karlsson S, Sundler F, Ahrén B. CCK receptor subtype in insulin-producing cells: A combined functional and in situ hybridization study in rat islets and a rat insulinoma cell line. Regul Pept 1998;78:95-103. (Pubitemid 28561522)
22. Reidelberger RD. Cholecystokinin and control of food intake. J Nutr 1994;124:1327S-1333S. (Pubitemid 24283395)
23. Degen L, Matzinger D, Drewe J, Beglinger C. The efect of cholecystokinin in controlling appetite and food intake in humans. Peptides 2001;22:1265-1269. (Pubitemid 32703695)
24. Bastard J P, Hainque B, Dusserre E, Bruckert E, Robin D, Vallier P, Perche S, et al. Peroxisome proliferator activated receptor-γ, leptin and tumor necrosis factor-α mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women. Diabetes Metab Res Rev 1999;15:92-98. (Pubitemid 29253762)
25. Vamecq J, Latrufe N. Peroxisome proliferator-activated receptors (PPARs) and their implications in diseases. Curr Opin Endocrinol Diabetol 2000;7:8-18. (Pubitemid 30127792)
26. González Sánchez JL, Serrano Ríos M, Fernández Perez C, Laakso M, Martínez Larrad MT. Efect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ-2 gene on adiposity, insulin sensitivity and lipid profle in the Spanish population. Eur J Endocrinol 2002;147:495-501. (Pubitemid 35238145)
27. Simón I, Vendrell J, Gutiérrez C, Fernández-Real JM, Vendrell I, Gallart L, Fontova R, Richart C. Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ is associated with increased leptin levels in women with type-2 diabetes mellitus. Horm Res 2002;58:143-149.
28. Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J. Association between peroxisome proliferator-activated receptor γ haplotypes and the metabolic syndrome in French men and women. Diabetes 2005;54:3043-3048. (Pubitemid 41401107)
29. Ben Ali S, Ben Yahia F, Sediri Y, Kallel A, Ftouhi B, Feki M, Elasmi M, et al. Gender-specifc efect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor γ-2 gene on obesity risk and leptin levels in a Tunisian population. Clin Biochem 2009;42:1642-1647.
30. Hahn S, Fingerhut A, Khomtsiv U, Khomtsiv L, Tan S, Quadbeck B, Herrmann BL, et al. The peroxisome proliferator activated receptor γ Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2005;62:573-579. (Pubitemid 40646724)
31. Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Cakir N, Arslan M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ gene in women with polycystic ovary syndrome. Gynecol Endocrinol 2006;22:336-342. (Pubitemid 43941411)
32. San-Millán JL, Escobar-Morreale HF. The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): An original case-control study followed by systematic review and meta-analysis of existing evidence. Clin Endocrinol (Oxf) 2010;72:383-392.